Circulation problems in the brain’s seat of memory linked to mild cognitive impairment in older adults

Mild cognitive impairment is linked to blood vessel dysfunction in the brain’s temporal lobes — the seat of memory — according to a new USC-led study.

The findings, seen in people with and without signs of amyloid buildup in the brain, suggest that microvascular trouble may be an important, early biomarker for dementia as well as a potential target for therapy.

The research, involving scientists from multiple universities, appears in the journal Neurology.

“We’re studying the ability of these very small vessels to respond to stimuli and to dilate, and they’re showing dysfunction in people who have memory problems,” said senior author Daniel Nation, a professor of gerontology and medicine at the USC Leonard Davis School of Gerontology. “It could implicate blood vessel dysfunction in a very early stage of memory loss. It happened whether or not people had Alzheimer’s-related brain changes. They still had this blood vessel problem if they had memory issues.”

“Our findings underscore the need to focus on vascular health as a critical factor in memory decline,” said first author Arunima Kapoor, a graduate student at University of California, Irvine.

Nation said that some blood pressure drugs may potentially protect vascular function in a way that preserves memory, but more research is needed.

3 Likes

Very interesting. There is some contradictory, mixed and paradoxical data when it comes to blood pressure. It’s pretty clear that high BP in midlife is a big negative for health in general and the brain in particular. Meanwhile the picture becomes blurry in the old. Generally, BP goes up with age. This is hotly debated, because there have been suggestions that moderately higher BP in old age is brain protective. The thought is that with age the vascular system experiences stenosis. With less blood able to go through narrower vessels, you need greater blood pressure to push through and bring vital nutrients in and take the waste out. Conversely, low blood pressure in the old is sometimes associated with poor brain health. At least that was the view for some time, wherein there would be efforts made to get BP under control in middle age, but the standards for what constitutes treatable HBP in the old was slightly relaxed - I don’t know what the latest thinking is on the subject, are BP drugs prescribed in the old in borderline HBP cases?

4 Likes

Published in the journal Brain Research, the study highlights how physical activity not only protects healthy brain cells but also restores balance in the aging brain.

The research focused on the hippocampus, the brain region responsible for memory and learning, and measured the impact of aerobic exercise on key Alzheimer’s markers: amyloid plaques, tau tangles, and iron accumulation in myelin-producing cells known as oligodendrocytes. These markers are central to Alzheimer’s pathology.

3 Likes

What’s The Link Between The Two?

A variety of factors connect visceral fat to an increased risk of dementia. “We’ve known for at least 15 years that visceral fat is linked with lower brain volumes in healthy middle-aged adults,” says Moon.3She adds that, more recently, studies suggest a higher level of visceral fat in older adults is associated with worse cognition and damage to white matter (what helps conduct messages between brain cells) and a thinning of gray matter, which is made up of neurons that help us think, learn and remember.24

Cho J, Seo S, Kim WR, Kim C, Noh Y. Association between visceral fat and brain cortical thickness in the elderly: A neuroimaging study. Front Aging Neurosci. 2021;13:694629. doi:10.3389/fnagi.2021.694629.

Visceral fat is also an indirect risk factor for dementia because of the other types of conditions it is associated with, like diabetes.5 Pincus notes, “An older, but important meta-analysis of 28 studies showed a 73% increased risk of all type dementia, 56% increase of Alzheimer’s Disease, and 127% increase of vascular dementia in patients with diabetes.”6

Elevated blood sugar and its related conditions, such as high cholesterol and blood pressure, can impact blood vessels and cause inflammation. Pincus adds, “Chronic elevated blood glucose damages blood vessels in the brain while insulin resistance affects brain glucose metabolism.” This is important because the brain thrives on glucose and needs it to function optimally. Moon adds that damage to blood vessels can reduce the flow of oxygen and nutrients to the brain.

4 Likes

Rhonda Patrick of FoundMyFitness sends an email Newsletter to my inbox - The following cut/pasted from my email: Jan 16, 2025: The Case for Vitamin D in Dementia Prevention Well written and compelling reading (not sure about the accuracy of the science reporting).


Vitamin D isn’t just a vitamin—it’s a hormone that controls thousands of genes in the human body, many of which are in the brain.

The primary source of vitamin D is UVB radiation from the sun—which our skin uses to synthesize vitamin D3. Insufficient sun exposure, season changes in UVB, aging, and body weight can all affect our ability to produce vitamin D and its bioavailability. Because nearly 70% of the population has insufficient levels of vitamin D (blood levels <30 ng/mL) and a large percentage have deficient levels (<20 ng/mL), supplementing with vitamin D makes sense for most!

This might be especially true if you’re concerned about dementia risk (as we all should be).

In a study of over 12,000 dementia-free adults, those who used vitamin D had a 40% lower risk of dementia over a decade.

Remarkably, 84% of supplement users were dementia-free after five years, compared to just 68% of non-users. The benefits of vitamin D even extended to high-risk groups: In adults with mild cognitive impairment (MCI) and those who carried one or two copies of the APOE e4 allele—a major risk factor for neurodegenerative diseases—the risk of dementia was 33% lower compared to adults with MCI/APOE e4 carriers who didn’t use vitamin D.

While vitamin D reduced dementia risk across the board, some groups benefitted more.

Women, adults with normal cognition, APOE e4 non-carriers, and those without depression saw the greatest brain-protective effects from vitamin D supplementation.

Regardless of sex, genetic risk, or baseline cognition, the evidence is clear: Vitamin D is a powerful ally in reducing dementia risk. Though dosage details and optimal blood levels remain unknown, the link between vitamin D and brain health is too significant to ignore.

In today’s email, we’ll explore the importance of vitamin D for brain and body health and break down this study in more detail. I’ll also provide some practical takeaways about vitamin D supplementation.
­

­

Why Vitamin D Benefits the Brain

Vitamin D is linked to several benefits for human health.

  • Supports neurodevelopment: High-dose vitamin D supplementation in early childhood reduces the risk of internalizing behaviors such as depression and anxiety, especially in children with low prenatal vitamin D exposure.
  • Enhances brain function synergistically with exercise: Vitamin D supplementation combined with exercise improves functional brain connectivity in regions associated with memory and cognition.
  • Improves muscle strength and mass: Higher vitamin D levels enhance muscle strength and mass while reducing fat mass, likely through metabolic and hormonal pathways.
  • Promotes tooth remineralization: Vitamin D supplementation increases calcium and phosphorus in teeth, reducing the risk of demineralization and cavities.
  • Supports healthy aging: Vitamin D maintains genomic stability, mitochondrial function, and reduces cellular senescence, mitigating the hallmarks of aging.
  • Facilitates calcium homeostasis and bone health: Vitamin D regulates calcium absorption and bone remodeling, reducing the risk of osteoporosis and fractures, especially in aging populations.

Higher levels of vitamin D have also been associated with lower odds of dementia and mild cognitive impairment (MCI), better cognitive function, a reduction in Alzheimer’s disease risk, and larger total brain, gray matter, and hippocampal volumes.

How might vitamin D protect against dementia and Alzheimer’s?

Vitamin D helps clear amyloid beta aggregates which are considered to be one of the hallmarks of Alzheimer’s disease. It also appears to target another hallmark of Alzheimer’s disease—tau protein hyperphosphorylation. These effects have been attributed to less reactive oxygen species production, greater immune system clearance of amyloid beta proteins, and an increase in glial cell line-derived neurotrophic factor or GDNF—a brain protein that helps neurons survive and regenerate.

A 12-month randomized controlled trial found that vitamin D supplementation improved cognitive function, intelligence quotient scores, telomere length, and lowered oxidative stress markers in older adults with mild cognitive impairment (compared to placebo), suggesting that not only does vitamin D supplementation improve biomarkers of aging, but also functional outcomes.

Even though the study we’ll discuss today didn’t investigate these mechanisms, its results are still a testament to the importance of vitamin D for neurological health, especially later in life.
­
­
Quick pause! These weekly email deep dives are made possible by the generous contributions of FoundMyFitness members. I warmly invite you to become a Premium Member today. For just $15/month, you’ll gain access to everything we offer while helping us fulfill our mission of making science accessible to all! Learn more at the bottom of this email or by clicking the button below.
Become a Premium Member today!
­

Supplementing with Vitamin D Reduces Dementia Risk

The study included 12,388 adults who were divided into two groups: Those who reported using vitamin D supplements in any form (calcium-vitamin D, ergocalciferol/vitamin D2, or cholecalciferol/vitamin D3) and those who didn’t.

During the 10-year follow-up period, supplementing with vitamin D was associated with a 40% lower incidence of dementia: Over 2,000 participants who reported never using vitamin D supplements developed dementia compared to just 679 of those who used vitamin D.

Supplementing with vitamin D was also associated with a greater 5-year dementia-free survival—84% of adults in the vitamin D group were free of dementia during this time period while only 68% of the non users were dementia-free.

This was also true regardless of whether or not the participants had baseline MCI or normal cognitive function—vitamin D provided a benefit in both cases. While dementia prevalence was higher in adults with MCI, it was around 15% lower in this group for adults who supplemented with vitamin D compared to those who didn’t.
­

­
­

Some populations benefit more

Although vitamin D supplementation reduced dementia risk among all groups, there were several interesting findings regarding the benefits of vitamin D for certain populations:

  • Women derived a greater benefit from vitamin D: They experienced less dementia compared to men who supplemented. Furthermore, while vitamin D-using men had a 26% lower dementia incidence than non-using men, vitamin D-using women had a 49% lower incidence compared to non-using women.
  • Adults with normal baseline cognitive function had a 56% lower dementia incidence if they supplemented with vitamin D; however, adults with MCI had only a 33% lower incidence if they supplemented.
  • Among APOE e4 carriers, supplementing with vitamin D reduced the incidence of dementia by 33%, and among non-carriers, vitamin D reduced the incidence of dementia by 47%. Furthermore, among APOE e4 non-carriers, vitamin D use was associated with a 47% reduction in dementia incidence, while among carriers, vitamin D only mitigated dementia incidence by 33%.

Supplementing with vitamin D wasn’t enough to outweigh the effects of carrying one or two copies of the APOE e4 allele—these participants still had a 16% greater risk of dementia than non-carriers, even non-carriers who didn’t use vitamin D. The same was true for another risk factor—having MCI—which elevated dementia incidence by nearly 400% compared to having normal cognition, even in the presence of vitamin D supplementation.

Slowing the Decline for Those with Cognitive Impairment

Participants with MCI who didn’t supplement with vitamin D had more than a 600% increase in dementia risk compared to adults with normal cognitive function, even those who didn’t use vitamin D. But having MCI and supplementing with vitamin D offered some risk reduction—these participants’ dementia risk was 390% higher than adults with normal cognitive function—still high, but not as bad as having MCI and not using vitamin D!

It didn’t matter the form of vitamin D used—all of them were associated with a lower dementia risk. Specifically, using calcium-vitamin D was associated with a 44% lower dementia risk, using cholecalciferol (vitamin D3) was associated with a 37% lower risk, and ergocalciferol (vitamin D2) was associated with a 50% lower risk. Using combined forms of vitamin D was associated with a 50% lower risk.

Final Thoughts

These findings give strong support to the idea that everyone should probably be supplementing with at least some vitamin D to support optimal brain health.

This is especially true if you are exposed to risk factors for dementia like having one or more copies of the APOE e4 allele, mild cognitive impairment (or a family history of it), and others that weren’t investigated in this study like high blood pressure or metabolic dysfunction.

However, it is also important to note several caveats that warrant consideration. First, this was not a randomized controlled trial but an observational study, which introduces the potential for healthy user bias—adults who take supplements like vitamin D may also engage in other health-promoting behaviors that reduce dementia risk, independently of the supplement itself. Additionally, the study did not measure blood levels of vitamin D, so we lack insight into whether the observed effects were tied to correcting a deficiency or achieving a specific target range. Lastly, we don’t know the dose of vitamin D that was associated with health improvements—just whether participants used or didn’t use vitamin D supplements.

For these reasons, we can’t definitively say that vitamin D is certain to prevent dementia. But that doesn’t negate its critical importance for health. On that note, are some important and practical takeaways regarding vitamin D and your health.

  • Natural sunlight vs. supplementation: While sunlight exposure helps the body naturally regulate vitamin D synthesis, there is a natural built-in mechanism to prevent the body from producing too much vitamin D when in sunlight. This prevents toxicity.
  • Safe supplementation: Levels above 60 ng/mL of vitamin D are likely safe for most people. Levels up to 80 ng/mL have been shown to be associated with lower all-cause mortality, suggesting a beneficial range. Going above 80 ng/mL should be done with caution.
  • Avoiding toxicity: While vitamin D toxicity can occur with very high levels (especially through supplementation), a high dose taken daily for a long time is typically required to reach toxic levels. Commonly, it’s harder to reach toxic levels with moderate supplementation, and it’s unlikely unless extreme doses are taken consistently.
  • Consider your individual needs: Some people, particularly those with genetic factors (e.g., certain SNPs), may require higher doses to maintain optimal vitamin D levels. For example, some individuals may need 5,000 to 7,000 IU per day to reach levels of 30–40 ng/mL.
  • Standard doses probably aren’t sufficient: Large-scale studies often use standard low doses (e.g., 2,000 IU), but the results are inconclusive, particularly when participants’ starting levels aren’t considered. A better approach would be to adjust the dose to individual needs, aiming for higher target levels (e.g., 60 ng/mL or higher).
  • Monitoring blood levels: If you’re supplementing with vitamin D, monitor your blood levels regularly to ensure you’re maintaining an optimal range. If you’re aiming to achieve the highest levels safely, aim for levels between 60–80 ng/mL as these have shown potential benefits without the risks associated with high toxicity. However, always adjust based on personal needs and health factors, and consult a healthcare provider for personalized recommendations.
  • Avoid deficiency: Vitamin D levels below 30 ng/mL are considered insufficient, and levels above 40 ng/mL are generally beneficial for overall health. Vitamin D deficiency occurs at a blood level below 20 ng/mL.
    Interested in learning more about vitamin D and Rhonda’s current supplement routine? Check out these member-only Q&A episodes with detailed show notes that we’ve hand-picked to accompany this newsletter.
4 Likes

No? Vitamin D supplementation: no cognitive benefits in older adults with mild to moderate deficiency

5 Likes

The focus of Rhonda’s newsletter is the following study: Ghahremani M, Smith EE, Chen H-Y, Creese B, Goodarzi Z, Ismail Z. Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status. Alzheimer’s Dement . 2023; 15:e12404. https://doi.org/10.1002/dad2.12404

At a glance, the above study is an observational study of 10 years. In contrast to the study you give which is randomized control study for a period of 24 months. As a non-scientist I can’t speak with any expertise as to the significance of either study, but I will say Rhonda’s editorial team has made clear that they think the conclusions from the study are significant to act on

2 Likes

It’s very typical in medicine where deficiency of nutrient (vitamin in this case) is bad, but there is no further benefit from supplementation beyond meeting the minimal requirements

6 Likes

A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that the risk of dementia increases with age is well described. What’s new and startling about this result is the number. It’s double prior estimates.

The investigator team, led by researchers at New York University and funded by the National Institutes of Health, reported even higher risk estimates for women, people who self-report Black racial identity, and carriers of a form of a gene associated with Alzheimer’s disease, one of the common causes of dementia.

7 Likes

I wonder what the effect size of having a wife who listens to you is?

2 Likes

Researchers in China dug into the data and published their findings in January 2025 in The American Journal of Clinical Nutrition .5 Here’s what they found.

Data was pulled from the UK Biobank, a long-running database that houses anonymized health information and genetic data on half a million people living in the United Kingdom. For this study, more than 125,000 participants from the database met the inclusion criteria. One of these criteria included having completed a web-based 24-hour food diary at least twice during the 12-year follow-up period. This allowed researchers to determine how much dietary choline and choline-related compounds participants consumed on average. About 56% of the participants were women, and all participants had an average age of 56.

For dementia and Alzheimer’s, researchers found a U-shaped association with total choline intake. This means that people at the first and fourth quartiles experienced higher odds of developing dementia or Alzheimer’s. Those with the lowest odds of developing dementia and Alzheimer’s consumed, on average, about 354 mg/day and 338 mg/day of choline respectively. For context, that’s about as much choline as you would get from having two large eggs for breakfast in the morning.7

Source:

  1. Zuk E, Nikrandt G, Chmurzynska A. Dietary choline intake in European and non-European populations: current status and future trends—a narrative review. Nutrition Journal. 2024. doi:10.1186/s12937-024-00970-0
  2. National Institutes of Health. Choline.
  3. Dymek A, Oleksy Ł, Stolarczyk A, Bartosiewicz A. Choline—an underappreciated component of a mother-to-be’s diet. Nutrients. 2024. doi:10.3390/nu16111767
  4. Derbyshire E. Could we be overlooking a potential choline crisis in the United Kingdom? BMJ Nutrition, Prevention & Health. 2019. doi:10.1136/bmjnph-2019-000037
  5. Niu Y, Yan H, Zhong J, et al. Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study. The American Journal of Clinical Nutrition. 2025. doi:10.1016/j.ajcnut.2024.11.001
  6. Dementia Society of America. MCI.
  7. U.S. Department of Agriculture. FoodData Central. Eggs, Grade A, Large, egg whole.
  8. Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI Journal. 2021. doi: 10.17179/excli2020-3239
  9. National Institutes of Health. Choline.
9 Likes

Galantamine is a drug used to prevent dementia that reduces the breakdown of choline in the brain. Which also gives you amazing dreams and could prevent sarcopenia when taken with Metformin.

4 Likes


Mindfulness
and social engagement are the two lifestyle factors that offer protection for those who carry the gene with the greatest risk for developing Alzheimer’s disease, according to a new study by researchers at the University of Miami Miller School of Medicine.

The researchers at the Comprehensive Center for Brain Health found that carriers of the APOE4 gene who practiced mindfulness and engaged in social activities had greater cognitive reserve than those who did not.

“The implications of this study are that it supports integrating APOE4 screening into personalized cognitive health strategies as specific lifestyle interventions that might offer particular benefits for individuals at risk due to having this allele,” said lead author Deirdre O’Shea, Ph.D., assistant professor and clinical neuropsychologist at the Miller School.

Dr. O’Shea’s research focuses on understanding risk and resilience factors in cognitive dementia, especially by looking at cognitive reserve.

3 Likes

Source: x.com

4 Likes

Perhaps relevant for humans too…

Source: x.com

全文:Enhancing cognitive functions in aged dogs and cats: a systematic review of enriched diets and nutraceuticals

1 Like

Summary: The microbial ecosystems in our mouths may impact cognitive function as we age, with pathogenic bacteria linked to cognitive decline. Researchers found that beneficial bacteria, such as Neisseria, are associated with improved memory and attention, while harmful bacteria like Porphyromonas correlate with mild cognitive impairment.

These findings suggest that diet, particularly nitrate-rich foods, could promote beneficial bacteria and support brain health. Further research may reveal how oral health interventions could help delay cognitive decline and reduce the risk of dementia or Alzheimer’s disease.

Key Facts:

  • Microbial Connection: Beneficial oral bacteria, like Neisseria, support cognitive functions, while harmful bacteria, such as Porphyromonas, predict cognitive decline.
  • Dietary Influence: A nitrate-rich diet fosters beneficial oral bacteria linked to better cognitive outcomes.
  • APOE4 Link: Specific harmful bacteria (Prevotella intermedia) are associated with the APOE4 allele, a known risk factor for Alzheimer’s.

Open Access Paper:

Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype

Apolipoprotein E4 (APOE4 ) genotype and nitric oxide (NO) deficiency are risk factors for age-associated cognitive decline. The oral microbiome plays a critical role in maintaining NO bioavailability during aging. The aim of this study was to assess interactions between the oral microbiome, NO biomarkers, and cognitive function in 60 participants with mild cognitive impairment (MCI) and 60 healthy controls using weighted gene co-occurrence network analysis and to compare the oral microbiomes between APOE4 carriers and noncarriers in a subgroup of 35 MCI participants. Within the MCI group, a high relative abundance of Neisseria was associated with better indices of cognition relating to executive function (Switching Stroop, rs = 0.33, P = 0.03) and visual attention (Trail Making, rs = −0.30, P = 0.05), and in the healthy group, Neisseria correlated with working memory (Digit Span, rs = 0.26, P = 0.04). High abundances of Haemophilus (rs = 0.38, P = 0.01) and Haemophilus parainfluenzae (rs = 0.32, P = 0.03), that co-occurred with Neisseria correlated with better scores on executive function (Switching Stroop) in the MCI group. There were no differences in oral nitrate (P = 0.48) or nitrite concentrations (P = 0.84) between the MCI and healthy groups. Linear discriminant analysis Effect Size identified Porphyromonas as a predictor for MCI and Prevotella intermedia as a predictor of APOE4 -carrier status. The principal findings of this study were that a greater prevalence of oral P. intermedia is linked to elevated genetic risk for dementia (APOE4 genotype) in individuals with MCI prior to dementia diagnosis and that interventions that promote the oral Neisseria–Haemophilus and suppress Prevotella -dominated modules have potential for delaying cognitive decline.

https://academic.oup.com/pnasnexus/article/4/1/pgae543/7960038?login=false

5 Likes

Higher levels of amyloid, tau

Researchers followed 128 people with an average age of 70 from the neurology unit of the China-Japan Friendship Hospital in Beijing. Half had Alzheimer’s, and about one-third had mild cognitive impairment, a frequent precursor to Alzheimer’s. The rest had normal cognition.

The participants in the study slept overnight in the clinic, so researchers could measure their brainwave activity, eye movement, heartrate and breathing. Fitness trackers can capture some of this information, but it is less precise.

The researchers divided the participants into early and delayed REM sleep. On average, the early group reached REM less than 98 minutes after falling asleep, while the late group reached it more than 193 minutes after falling asleep.

Those with Alzheimer’s were more likely to have delayed REM sleep, and they also tended to have higher levels of the two toxic proteins, amyloid and tau, found in people with the condition.

Those with delayed REM sleep had 16% more amyloid and 29% more tau than those with early REM sleep. They also had 39% less of a healthy protein called brain derived neurotrophic factor (BDNF), which drops in Alzheimer’s.

7 Likes

Important result! Maybe finally all those gizmos that claim to detect what phase of sleep you are in can earn their keep, insofar as predicting the approach of AD, so you can take emergency measures desperately trying to avoid dementia, as excess tau is bad regardless of AD.

1 Like

Interesting speculation as to why high choline intake might correlate with dementia incidence:

“Wondering why a high intake of choline seemed to increase the odds of dementia and Alzheimer’s almost as much as the lowest intake did? Researchers explain that when choline intake exceeds the intestine’s capacity to absorb it all, the unabsorbed choline is changed into a compound called trimethylamine (TMA), which is further changed by the liver into trimethylamine N-oxide (TMAO). These substances are linked to heart disease, stroke and, yes, Alzheimer’s disease.8 Another explanation, according to the researchers, is that some common foods rich in choline are also high in saturated fat, and there has been a link between high saturated fat intake and dementia in previous studies.”

5 Likes

an argument for phosphatidylcholine…?

"Participants’ plasma TMAO levels increased significantly in all 3 intervention arms containing choline bitartrate (all P < .0001), but daily ingestion of 4 large eggs (P = .28) or phosphatidylcholine supplements (P = .27) failed to increase plasma TMAO levels.

5 Likes